<DOC>
	<DOCNO>NCT01879046</DOCNO>
	<brief_summary>Articular cartilage seat many disease include osteoarthritis traumatic default . The cartilage intrinsic ability repair result long term function loss joint . Currently available treatment satisfactory long term , use mesenchymal stem cell appear promise due ability multipotency immunomodulation property . This project aim determine appropriate source regenerative medicine cartilage stem cell tissue take arthroplasty patient osteoarthritis . These cell test different chondrogenic marker . The success project consider implementation strategy regenerative medicine bone joint disease .</brief_summary>
	<brief_title>Regenerative Medicine Articular Cartilage : Characterization Comparison Chondrogenic Potential Immunomodulatory Adult Mesenchymal Stem Cells</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Patients age 18 year Patients knee osteoarthritis Patients require total knee arthroplasty Patients sign consent form Patients age less 18 year Major Patients guardianship Pregnant woman Infectious pathology progressive tumor Refusal participate study State immunosuppression Congenital acquire malformation result deformation knee</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>articular cartilage</keyword>
	<keyword>tissue engineering</keyword>
	<keyword>immunomodulation</keyword>
	<keyword>osteo-arthritis</keyword>
</DOC>